| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 1 |
| 1 | EMPAGLIFLOZIN | 1 |
| 2 | NATALIZUMAB | 1 |
| 3 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 1 | 0.0009 |
| 1 | EMPAGLIFLOZIN | 1 | 0.0000 |
| 2 | NATALIZUMAB | 1 | 0.0000 |
| 3 | DUPILUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 1 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 1 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |